FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2412534997> ?p ?o ?g. }

• W2412534997 endingPage "88" @default.
• W2412534997 startingPage "78" @default.
• W2412534997 abstract "Inhibition of tumor necrosis factor (TNF) activity has profoundly changed the management of several immune-mediated inflammatory diseases with great benefit for patients. The application of TNF inhibitors (TNFi), however, also brings a new concern, malignancy. We performed a systemic review to collect the studies reporting cancer incidences and risks in TNFi users regardless of indications. TNFi were most frequently used in treating patients with rheumatoid arthritis (RA) and inflammatory bowel diseases (IBD). In RA patients without prior cancer history, the incidences of malignancies ranged from the lowest rate 0 per 1000 person-years in etanercept users regarding lymphoma to the highest rate 35.62 per 1000 person-years in adalimumab users on non-melanoma skin cancer (NMSC), while in those patients with prior cancer history, the recurrent incidences of malignancies ranged from the lowest rate 5.05 per 1000 person-years regarding melanoma to the highest rate 63.20 per 1000 person-years on basal cell carcinoma (BCC) in TNFi users. In IBD patients, incidences ranged from 0 per 1000 person-years in TNFi users on lymphoma to 34.0 per 1000 person-years in infliximab users on overall cancer. However, these incidence rates of overall cancer, lymphoma and melanoma were not higher in comparison with those patients who were not treated with TNFi. Compared to general population, incidences of lymphoma were elevated in RA patients and rates of NMSC were higher in patients with psoriasis, RA and IBD. In conclusion, cancer incidences vary across different studies, indications, cancer types and studies with different individual TNFi. Treatment with TNFi is not associated with increased malignant risks of overall cancer, lymphoma or melanoma. Results of NMSC risk were inconsistent among studies. A latest prospective registry study demonstrated a small increased risk of squamous cell cancer in RA patients treated with TNFi (one additional case for every 1600 years of treatment experience). Further prospective studies are needed to verify whether TNFi users have higher NMSC risk than non-TNFi users." @default.
• W2412534997 created "2016-06-24" @default.
• W2412534997 creator A5005285992 @default.
• W2412534997 creator A5015084747 @default.
• W2412534997 creator A5017940721 @default.
• W2412534997 creator A5028065323 @default.
• W2412534997 creator A5058637832 @default.
• W2412534997 date "2018-01-01" @default.
• W2412534997 modified "2023-10-17" @default.
• W2412534997 title "Do tumor necrosis factor inhibitors increase cancer risk in patients with chronic immune-mediated inflammatory disorders?" @default.
• W2412534997 cites W1534752358 @default.
• W2412534997 cites W1852055234 @default.
• W2412534997 cites W1858749428 @default.
• W2412534997 cites W1886567006 @default.
• W2412534997 cites W1892676932 @default.
• W2412534997 cites W1948887633 @default.
• W2412534997 cites W1971219506 @default.
• W2412534997 cites W1973289259 @default.
• W2412534997 cites W1974943298 @default.
• W2412534997 cites W1977445011 @default.
• W2412534997 cites W1979107859 @default.
• W2412534997 cites W1986109277 @default.
• W2412534997 cites W1988201936 @default.
• W2412534997 cites W1991973624 @default.
• W2412534997 cites W1995244547 @default.
• W2412534997 cites W2002647452 @default.
• W2412534997 cites W2009928292 @default.
• W2412534997 cites W2013627195 @default.
• W2412534997 cites W2019886362 @default.
• W2412534997 cites W2037551631 @default.
• W2412534997 cites W2045299609 @default.
• W2412534997 cites W2045789990 @default.
• W2412534997 cites W2055176162 @default.
• W2412534997 cites W2057123987 @default.
• W2412534997 cites W2058321458 @default.
• W2412534997 cites W2062694326 @default.
• W2412534997 cites W2070021262 @default.
• W2412534997 cites W2074007950 @default.
• W2412534997 cites W2095807833 @default.
• W2412534997 cites W2103270747 @default.
• W2412534997 cites W2103456976 @default.
• W2412534997 cites W2104307666 @default.
• W2412534997 cites W2105532585 @default.
• W2412534997 cites W2106249804 @default.
• W2412534997 cites W2107448760 @default.
• W2412534997 cites W2111247729 @default.
• W2412534997 cites W2111624359 @default.
• W2412534997 cites W2112639375 @default.
• W2412534997 cites W2114703915 @default.
• W2412534997 cites W2116640162 @default.
• W2412534997 cites W2119723369 @default.
• W2412534997 cites W2121410450 @default.
• W2412534997 cites W2123254493 @default.
• W2412534997 cites W2125657144 @default.
• W2412534997 cites W2126510103 @default.
• W2412534997 cites W2131254861 @default.
• W2412534997 cites W2133633410 @default.
• W2412534997 cites W2144399580 @default.
• W2412534997 cites W2144824470 @default.
• W2412534997 cites W2147648627 @default.
• W2412534997 cites W2148189437 @default.
• W2412534997 cites W2148201023 @default.
• W2412534997 cites W2149521567 @default.
• W2412534997 cites W2153124348 @default.
• W2412534997 cites W2154150857 @default.
• W2412534997 cites W2154511254 @default.
• W2412534997 cites W2154986972 @default.
• W2412534997 cites W2159728707 @default.
• W2412534997 cites W2167404036 @default.
• W2412534997 cites W2169252033 @default.
• W2412534997 cites W2169778736 @default.
• W2412534997 cites W2170193889 @default.
• W2412534997 cites W2180349132 @default.
• W2412534997 cites W2255538192 @default.
• W2412534997 cites W2297295070 @default.
• W2412534997 cites W982805405 @default.
• W2412534997 cites W985856533 @default.
• W2412534997 doi "https://doi.org/10.1016/j.cyto.2016.09.013" @default.
• W2412534997 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27688201" @default.
• W2412534997 hasPublicationYear "2018" @default.
• W2412534997 type Work @default.
• W2412534997 sameAs 2412534997 @default.
• W2412534997 citedByCount "50" @default.
• W2412534997 countsByYear W24125349972018 @default.
• W2412534997 countsByYear W24125349972019 @default.
• W2412534997 countsByYear W24125349972020 @default.
• W2412534997 countsByYear W24125349972021 @default.
• W2412534997 countsByYear W24125349972022 @default.
• W2412534997 countsByYear W24125349972023 @default.
• W2412534997 crossrefType "journal-article" @default.
• W2412534997 hasAuthorship W2412534997A5005285992 @default.
• W2412534997 hasAuthorship W2412534997A5015084747 @default.
• W2412534997 hasAuthorship W2412534997A5017940721 @default.
• W2412534997 hasAuthorship W2412534997A5028065323 @default.
• W2412534997 hasAuthorship W2412534997A5058637832 @default.
• W2412534997 hasConcept C120665830 @default.
• W2412534997 hasConcept C121332964 @default.
• W2412534997 hasConcept C121608353 @default.

• next